Emkay economist sees $6-7 billion hit if US tariffs apply to India

Share it

Madhavi Arora, Chief Economist at Emkay Global Financial Services, pointed out that India has strong bargaining power, especially in pharmaceuticals, where Indian generics play a vital role in the US market. This sector could be a key part of negotiations for a trade deal.

Leave a Comment

Your email address will not be published. Required fields are marked *